John Rogers Ariel Investments
John W. Rogers Jr. is the founder of Ariel Investments, one of the best-known minority-owned investment firms in the United States. Ariel is associated with patient, value-oriented investing and a long-term “slow and steady” culture. Rogers is also a prominent voice on markets, corporate leadership, and inclusive capitalism.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madison Square Garden
MSGE
|
+$240M |
| 2 |
Charles River Laboratories
CRL
|
+$72.6M |
| 3 |
Carlyle Group
CG
|
+$70.5M |
| 4 |
Leslie's
LESL
|
+$49M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Caribbean
RCL
|
+$57M |
| 2 |
Microsoft
MSFT
|
+$49.2M |
| 3 |
Sphere Entertainment
SPHR
|
+$42.2M |
| 4 |
CBRE Group
CBRE
|
+$35.1M |
| 5 |
nVent Electric
NVT
|
+$30.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.37% |
| 2 | Financials | 18.13% |
| 3 | Industrials | 16.42% |
| 4 | Communication Services | 15.71% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Baidu
BIDU
$31.6B
| $377M | 3.57% |
2,756,228
-78,555
| -3% | -$10.3M |
|
2
Mattel
MAT
$4.15B
| $322M | 3.05% |
16,466,014
+187,157
| +1% | +$3.38M |
|
3
Philip Morris
PM
$293B
| $291M | 2.75% |
2,979,537
+50,781
| +2% | +$4.85M |
|
4
Kennametal
KMT
$2.28B
| $280M | 2.66% |
9,877,760
-310,079
| -3% | -$8.31M |
|
5
Generac Holdings
GNRC
$12.2B
| $261M | 2.47% |
1,749,294
+86,511
| +5% | +$9.86M |
|
6
Gentex
GNTX
$4.98B
| $247M | 2.34% |
8,450,923
-480,767
| -5% | -$13.3M |
|
7
Resideo Technologies
REZI
$3.08B
| $246M | 2.33% |
13,958,059
-134,622
| -1% | -$2.32M |
|
|
8
Microsoft
MSFT
$3.59T
| $244M | 2.31% |
716,331
-157,142
| -18% | -$49.2M |
|
9
Jones Lang LaSalle
JLL
$17.8B
| $237M | 2.24% |
1,520,409
+72,334
| +5% | +$10.3M |
|
|
10
Madison Square Garden
MSGE
$3.78B
| $235M | 2.23% |
+6,997,080
| New | +$240M |
|
11
Lazard
LAZ
$4.3B
| $232M | 2.2% |
7,260,662
-118,085
| -2% | -$3.65M |
|
12
Core Laboratories
CLB
$574M
| $224M | 2.12% |
9,631,723
+122,495
| +1% | +$2.77M |
|
|
13
Charles River Laboratories
CRL
$14.1B
| $220M | 2.09% |
1,047,840
+364,786
| +53% | +$72.6M |
|
14
First American
FAF
$7.33B
| $219M | 2.07% |
3,838,309
-157,621
| -4% | -$8.9M |
|
15
Boyd Gaming
BYD
$5.87B
| $216M | 2.04% |
3,112,821
-342,299
| -10% | -$23M |
|
16
Credicorp
BAP
$30.1B
| $211M | 1.99% |
1,426,147
-30,943
| -2% | -$4.25M |
|
|
17
Royal Caribbean
RCL
$78.1B
| $210M | 1.99% |
2,028,952
-727,326
| -26% | -$57M |
|
18
Mohawk Industries
MHK
$9.23B
| $204M | 1.93% |
1,981,126
+12,258
| +0.6% | +$1.2M |
|
|
IPG
19
DELISTED
Interpublic Group of Companies
IPG
| $198M | 1.88% |
5,141,660
-716,369
| -12% | -$27M |
|
20
BOK Financial
BOKF
$8.54B
| $191M | 1.81% |
2,366,764
-199,947
| -8% | -$16.5M |
|
|
SRCL
21
DELISTED
Stericycle Inc
SRCL
| $190M | 1.8% |
4,094,424
-102,100
| -2% | -$4.47M |
|
22
Northern Trust
NTRS
$33.6B
| $186M | 1.76% |
2,506,051
+132,116
| +6% | +$10.1M |
|
23
Axalta
AXTA
$7.75B
| $185M | 1.75% |
5,626,019
-808,431
| -13% | -$25.1M |
|
24
Madison Square Garden
MSGS
$9.78B
| $179M | 1.7% |
952,096
-101,071
| -10% | -$19.1M |
|
|
25
Carlyle Group
CG
$17.6B
| $174M | 1.65% |
5,446,414
+2,413,794
| +80% | +$70.5M |
|
Similar funds
John Rogers's Q2 2023 Portfolio in Review
As of Q2 2023, John Rogers held 119 positions worth $10.6B, up 1.5% from $10.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
John Rogers's Q2 2023 filing shows 5 new, 33 increased, 72 reduced and 3 closed positions. Its largest new stake was Madison Square Garden: 6,997,080 shares worth $235M. The largest sale was Royal Caribbean, an estimated $57M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- John Rogers's largest Q2 2023 buy was Madison Square Garden: 6,997,080 shares worth $235M.
- John Rogers added most to Charles River Laboratories in Q2 2023, an estimated $72.6M increase.
- John Rogers's biggest Q2 2023 reduction was Royal Caribbean, cutting an estimated $57M.
- John Rogers fully exited Cardinal Health in Q2 2023, selling an estimated $19.5M.
- John Rogers's ten largest holdings make up 26% of its $10.6B portfolio in Q2 2023.
- John Rogers opened 5 new positions and closed 3 in Q2 2023.
- John Rogers's portfolio value rose 1.5% quarter-over-quarter to $10.6B.
Based on Ariel Investments's 13F filing for Q2 2023, filed 14 Aug 2023.